Enterprise Europe Network

A Maltese-based company that has developed a neurological tool to measure mental function and early dementia detection is looking for a commercial agency or distribution services agreement.

Country of origin:
Country: 
MALTA
Opportunity:
External Id: 
BOMT20201015001
Published
15/10/2020
Last update
11/11/2020
Expiration date
12/11/2021

Keywords

Partner keyword: 
Diagnostic services
Other diagnostic
Diagnostic equipment
Geriatrics
Cognitive aid
Other human health activities
EXPRESS YOUR INTEREST

Summary

Summary: 
A Maltese team of brain enthusiasts with backgrounds in cognitive science, neuroscience, and clinical work have developed an easy to use and mobile EEG-based (electroencephalogram) method of early dementia diagnosis. This SME is looking for a commercial agency or a distribution services agreement with partners active in the dementia-care market or the medical field.

Description

Description: 

This Maltese-based company's team of experts consisting of neuroscientists, cognitive scientists, programmers, social scientists, and translators have developed a novel approach to detecting mental decline which can serve as a rapid tool for early dementia diagnosis. This is conducted through the use of their tool, an objective measure of cognitive abilities based on fully automatic neuro-scientific brain-wave analysis. The early dementia detection model put forward by this SME can help those suffering from dementia reclaim several healthy life years.They are expected to attain the CE class I medical device certification in March-April 2021, and the class 2A medical device certification in Q2 2023. They are interested in collaborations with partners in the medical field, particularly with hospitals, retirement homes, and nursing homes that are looking for a kind of tool offered by this company. A commercial agency agreement or distribution agency agreement is sought.

Advantages & innovations

Cooperation plus value: 
-The diagnostic algorithm that this company has developed is faster than any other method currently used in dementia diagnosis. - It is non-invasive and safe - Electroencephalogram (EEG) testing is affordable - Electroencephalogram (EEG)-based biomarker can be used by a minimally trained staff at any facility - A timely and more wide-reaching diagnosis of dementia, which leads to reduced long-term costs, reduction of associated diseases. - The team is composed of experts in cognitive science, neuroscience, and medicine. - Years-long experience in clinical work and research expertise in dementia-related diseases

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
This Maltese SME is seeking to collaborate or do business with partners/agents from the wellness sector or healthcare/medical field with particular interest in dementia. Hospitals, nursing homes, clinics, and healthcare centers could be interested in such a cooperation. They would like to expand their business network and therefore reliable partners are sought under a commercial agency agreement or distribution agency agreement.

Type and size

Cooperation task: 
SME 11-50,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500

Dissemination

Dissemination sector group : 
Dissemination preferred : 
Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, USA

braintrip_logo_barvni_09.png

Dementia screening